The co-overexpression of miR-29 in DMD mice with micro-dystrophin restores fibrosis and muscle function to a similar levels to that of normal mice, suggesting a possible combination treatment strategy [83]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.